Chugai Pharmaceutical Co., Ltd. ( CHGCY) - Stock Earnings
CHGCY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 27, 2026 AfterMarket | — / — | — | — / — | — |
CHGCY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 941.6 million USD | 2.6 billion USD |
| 2026Q1 | 735.9 million USD | 2.1 billion USD |
| 2026Q2 | 724.7 million USD | 2.1 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CHGCY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 2.3 billion USD | 7.9 billion USD |
| 2024 | 2.5 billion USD | 7.5 billion USD |
| 2025 | 2.9 billion USD | 8.4 billion USD |
| 2026 Est. | — | — |
CHGCY
Price: $21.59
52 week price:
Dividend Yield: 2.92%
Payout Ratio Range:
Earnings Per Share: 0.87 USD
P/E Ratio: 24.62
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 71.6 billion